RxDoctor Payments Data

David Kuwayama, MD

Vascular Surgery · Lebanon, NHNPI 1265591333

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $7,228 of the $10,648 with a category attached, or 67.9%. 8 manufacturers reported payments, led by Cook Medical LLC at 33.4% of the total. Reporting peaked in 2024 at $3,803 and has fallen 98.8% since, to $47 in 2025.

$10,648in general payments, 2019–2025

Across 77 payments — averaging $138.28 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cook Medical LLC$4K
  • W. L. Gore & Associates, Inc.$3K
  • Bolton Medical Inc$1K
  • Boston Scientific$1K
  • Cook Incorporated$1K
  • Endologix LLC$121
  • plus $86 from 2 others
$27,954in research payments, 2019–2025

Across 7 payments — averaging $3993.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Medtronic$18K
  • W. L. Gore & Associates, Inc.$10K
$150,000in ownership & investment interests, 2019–2025

Across 1 payment — averaging $150,000 each. An ownership or investment interest held by the physician or an immediate family member.

  • Shape Memory Medical Inc.$150K

What the payments were for

  • Travel & lodging$7,22868%
  • Food & beverage$3,41932%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,648 in reported general payments places this provider in the 85th percentile of 43 vascular surgery providers in New Hampshire.

See all vascular surgery providers in New Hampshire

Medicare billing

Part B allowed, 2024
$85,770
Medicare patients
70
Services billed
237

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ClopidogrelClopidogrel Bisulfate12$160

Paid to pharmacies, not to this prescriber.

Other vascular surgery in Lebanon

See the full list for New Hampshire

Where these figures come from

Is this you, or does something look wrong? →